Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Delayed Release Prednisone in PMR

ClinicalTrials.gov ID: NCT02702778

Public ClinicalTrials.gov record NCT02702778. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-label, Dose-ranging Study of Oral Delayed Release Prednisone in Patients With Untreated Polymyalgia Rheumatic (PMR)

Study identification

NCT ID
NCT02702778
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Dinora, Inc.
Other
Enrollment
8 participants

Conditions and interventions

Interventions

  • Delayed-Release (DR) Prednisone Drug
  • Immediate Release (IR) Prednisone Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2016
Primary completion
Dec 30, 2016
Completion
Mar 30, 2017
Last update posted
May 2, 2017

2016 – 2017

United States locations

U.S. sites
6
U.S. states
4
U.S. cities
5
Facility City State ZIP Site status
Clinical Research Site Miami Florida
Clinical Research Site Mineola New York
Clinical Research Site Duncansville Pennsylvania
Clinical Research Site 2 Wyomissing Pennsylvania
Clinical Research Site Wyomissing Pennsylvania
Clinical Research Site Spokane Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02702778, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 2, 2017 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02702778 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →